Therapeutic Asset Ratings
1,055 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dabrafenib
Ovarian Neoplasm
Cancer Research UK
P2/3
CCC
(52)
Duloxetine
Colorectal Cancer
Alliance for Clinical Trials in Oncology
P2/3
CCC
(52)
eik1001
Melanoma
Eikon Therapeutics
P2/3
CCC
(52)
Empagliflozin
Cystic Fibrosis
University of Minnesota
P2/3
CCC
(52)
Entrectinib
Glioma
Cancer Research UK
P2/3
CCC
(52)
Fianlimab
Non-Small Cell Lung Carcinoma
Montefiore Medical Center
P2/3
CCC
(52)
Flutamide
Metastatic Prostate Carcinoma
VA Office of Research and Development
P2/3
CCC
(52)
Futibatinib
Metastatic Malignant Neoplasm
Taiho Oncology, Inc.
P2/3
CCC
(52)
Galantamine Hydrobromide
Abdominal Obesity-Metabolic Syndrome
Northwell Health
P2/3
CCC
(52)
Gx
Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and Hospital
P2/3
CCC
(52)
Histrelin
Metastatic Prostate Carcinoma
VA Office of Research and Development
P2/3
CCC
(52)
hs-20117
Non-Small Cell Lung Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P2/3
CCC
(52)
Hydrogen
Parkinson Disease
dr. Siti Nurlaela, SpN
P2/3
CCC
(52)
Icp-248
Hematopoietic And Lymphoid System Neoplasm
Beijing InnoCare Pharma Tech Co., Ltd.
P2/3
CCC
(52)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Colorectal Neoplasm
Cancer Research UK
P2/3
CCC
(52)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Ovarian Neoplasm
Cancer Research UK
P2/3
CCC
(52)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Pancreatic Neoplasm
Cancer Research UK
P2/3
CCC
(52)
ip-001
Colorectal Cancer
Immunophotonics, Inc.
P2/3
CCC
(52)
ip-001
Rectal Carcinoma
Immunophotonics, Inc.
P2/3
CCC
(52)
Iza-Bren
Non-Small Cell Lung Carcinoma
M.D. Anderson Cancer Center
P2/3
CCC
(52)
KETOROLAC
Prostate Cancer
Wake Forest University Health Sciences
P2/3
CCC
(52)
L-ACETYL CARNITINE
Amyotrophic Lateral Sclerosis
Mario Negri Institute for Pharmacological Research
P2/3
CCC
(52)
Maralixibat
Cystic Fibrosis
Children's Hospital Los Angeles
P2/3
CCC
(52)
Memantine
Cirrhosis Of Liver
Inova Health Care Services
P2/3
CCC
(52)
Mirabegron
Ovarian Cancer
Obstetrics & Gynecology Hospital of Fudan University
P2/3
CCC
(52)
Showing 876 to 900 of 1,055 assets
Previous
Page 36 of 43
Next